Cancer-Related Cognitive Changes

Asher, Arash; Dyk, Kathleen Van; Patel, Sunita K.; Newman, Robin; Engle, Jessica P.; Hutchison, Nancy A; Padgett, Lynne

doi:10.1016/j.apmr.2017.05.011

Cited by 2 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The initial cognitive test results and emotional wellbeing were in association with later depression and anxiety. in vivo 33: 1381-1392 (2019) Our results reassure the need of early assessment of cognitive functioning, mood and QOL in order to implement intervention if needed (41). If on the basis of initial cognitive deficit and QOL characteristics risk individuals could be identified, this would imply special intervention for the prevention of later depression or anxiety during the followup care of BC survivors (41,42).…”

Section: Discussionmentioning

confidence: 68%

Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy

Biró

Kahán

Kálmán

et al. 2019

In Vivo

View full text Add to dashboard Cite

Background/Aim: Anti-cancer therapies may deteriorate cognitive functioning, affective functioning and psychological well-being. Materials and Methods: In this prospective longitudinal pilot study, premenopausal and postmenopausal patients received adjuvant endocrine therapy (ET) (tamoxifen with or without LHRH analog or aromatase inhibitor) or were observed only (control group). At baseline testing and 6, 12 and 24 months thereafter, cognitive, depression and anxiety tests and quality of life (QOL) measurements were performed. Results: Overall, 46 cases were evaluated. None of the studied cognitive parameters differed between the subgroups or changed by time. No differences were found regarding anxiety, depression or QOL measures either. Baseline cognitive test and QOL results were in association with later anxiety and depression. Conclusion: No cognitive impairment was found during the two years of ET. Baseline cognitive scores and QOL dimensions proved good predictors of later anxiety and depression.

show abstract

Section: Discussionmentioning

confidence: 68%

Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy

Biró

Kahán

Kálmán

et al. 2019

In Vivo

View full text Add to dashboard Cite

show abstract

“…This may involve establishing a referral network within and outside the local institution with the requisite skills to effectively address patient symptoms and problems. To address a potential knowledge gap, Table 2 provides an overview of the 12 most common cancer‐related symptoms/problems and recommendations for evidence‐based, targeted interventions to address each 40,42,111,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203 …”

Section: Intervention Characteristicsmentioning

confidence: 99%

Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work

Deshields

Gregorio

Flowers

et al. 2021

CA A Cancer J Clinicians

Self Cite

View full text Add to dashboard Cite

Distress management (DM) (screening and response) is an essential component of cancer care across the treatment trajectory. Effective DM has many benefits, including improving patients' quality of life; reducing distress, anxiety, and depression; contributing to medical cost offsets; and reducing emergency department visits and hospitalizations. Unfortunately, many distressed patients do not receive needed services. There are several multilevel barriers that represent key challenges to DM and affect its implementation. The Consolidated Framework for Implementation Research was used as an organizational structure to outline the barriers and facilitators to implementation of DM, including: 1) individual characteristics (individual patient characteristics with a focus on groups who may face unique barriers to distress screening and linkage to services), 2) intervention (unique aspects of DM intervention, including specific challenges in screening and psychosocial intervention, with recommendations for resolving these challenges), 3) processes for implementation of DM (modality and timing of screening, the challenge of triage for urgent needs, and incorporation of patient-reported outcomes and quality measures), 4) organization-inner setting (the context of the clinic, hospital, or health care system); and 5) organization-outer setting (including reimbursement strategies and health-care policy). Specific recommendations for evidence-based strategies and interventions for each of the domains of the Consolidated Framework for Implementation Research are also included to address barriers and challenges.

show abstract

Cancer-Related Cognitive Changes

Cited by 2 publications

References 6 publications

Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy

Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy

Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work

Contact Info

Product

Resources

About